370 Pharmacodynamic assessment of a novel FAP-targeted 4–1BB agonist, administered as single agent and in combination with atezolizumab to patients with advanced solid tumors

Authors :: Josep Tabernero
Maurizio Ceppi
Victor Moreno
Michael Hettich
Miguel Sanmamed
Christina Claus
Tatiana Hernandez
Iben Spanggaard
Analia Azaro
Maria Martinez Garcia
Alejo Rodriguez-Vida
Florian Heil
Oliver Krieter
Oliver Grimm
Marta Canamero
Jose Duarte
Alexandra-Cristina Nica
Iakov Davydov
Chia-Huey Ooi
Christian Heichinger
Ernesto Guarin
Radoiane Helbaj
Tamara Tanos
Eveline Nueesch
Irene Moreno
Source :: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Publication Year :: 2020
Publisher :: BMJ Publishing Group, 2020.

Subjects :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools